Transgender hormone therapy (female-to-male)
Transgender Hormone Therapy (Female-to-Male)[edit | edit source]
Introduction[edit | edit source]
Transgender hormone therapy for female-to-male (FTM) individuals, also known as gender-affirming hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender individuals to more closely align their secondary sexual characteristics with their gender identity. This therapy primarily involves the administration of testosterone to induce masculinizing effects.
Hormones Used[edit | edit source]
The primary hormone used in FTM hormone therapy is testosterone. It is available in various forms, including injections, transdermal patches, gels, and occasionally, oral medications.
Testosterone[edit | edit source]
- Injections - Intramuscular or subcutaneous injections are common and typically administered weekly or biweekly.
- Patches and Gels - Transdermal options provide a steady hormone level and are daily alternatives to injections.
- Oral Medications - Less commonly used due to potential liver concerns but available in some cases.
Effects of Hormone Therapy[edit | edit source]
FTM hormone therapy leads to various physical and psychological changes. The onset and degree of these changes can vary widely among individuals.
Physical Changes[edit | edit source]
- Deepening of the voice
- Growth of facial and body hair
- Redistribution of body fat and increased muscle mass
- Cessation of menstruation
- Clitoral enlargement
- Possible male-pattern baldness
Psychological and Emotional Changes[edit | edit source]
- Many report improved psychological well-being
- Increases in energy levels
- Possible changes in sexual orientation or libido
Health Considerations[edit | edit source]
Before starting hormone therapy, individuals undergo thorough medical evaluations. Ongoing monitoring is necessary to assess the effects of the therapy and manage any potential health risks.
Risks and Side Effects[edit | edit source]
- Changes in cholesterol and lipid profiles
- Increased red blood cell count
- Potential impacts on liver function
- Changes in mood or mental health
Informed Consent[edit | edit source]
Informed consent is a critical component of transgender hormone therapy. Patients should be fully aware of the benefits, risks, and irreversible changes associated with hormone therapy.
See Also[edit | edit source]
External Links[edit | edit source]
- World Professional Association for Transgender Health (WPATH) Standards of Care
- National Center for Transgender Equality - Health and Wellness
This article is a stub. You can help WikiMD by registering to expand it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen